Journal of Acupuncture and Tuina Science

, Volume 15, Issue 2, pp 115–119 | Cite as

Effect of warm needling plus oral medication on blood lipids in cerebral infarction patients

  • Zhen-jie Xu (徐贞杰)
  • Wei Qi (漆伟)
  • Yi Liu (刘奕)
Special Topic Study
  • 7 Downloads

Abstract

Objective

To observe the effect of warm needling plus oral administration of rosuvastatin calcium tablets on blood lipids in cerebral infarction patients.

Methods

A total of 125 eligible cases were randomly allocated into group A (n=42), group B (n=40) and group C (n=43). Cases in group A received warm needling plus oral administration of rosuvastatin calcium tablets, cases in group B received warm needling, whereas cases in group C received oral administration of rosuvastatin calcium tablets.

Results

After treatment, the total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C) all dropped obviously in the three groups, with significant differences (all P<0.05), modified Barthel index (BI) scores all significantly rise (all P<0.05), and high-density lipoprotein cholesterol (HDL-C) remained unchanged (all P>0.05). After treatment, the changes of TC, TG and LDL-C in group A were significantly different from those in group B and group C (all P<0.05), while the changes showed no statistical significance between group B and group C (P>0.05). There were no between-group differences in HDL-C among the three groups (all P>0.05); the modified BI scores in group A and group B were significantly higher than that in group C (both P<0.05), while there was no significant difference between group A and group B (P>0.05). After treatment, the total effective rate was significantly higher in group A than that in group B and group C (both P<0.05), there was no significant difference between group B and group C (P>0.05).

Conclusion

Warm needling and oral administration of rosuvastatin calcium tablets both can adjust blood lipids effectively in cerebral infarction patients with a similar therapeutic efficacy, while the effect gets better based upon combining both methods; acupuncture-moxibustion plays an important role in the recovery of nerve functions in cerebral infarction patients.

Keywords

Acupuncture Therapy Moxibustion Therapy Warm Needling Therapy Cerebral Infarction Blood Lipid Rosuvastatin Calcium Tablets 

温针灸结合口服药物对脑梗死患者血脂的影响

摘要

目的

观察温针灸结合口服瑞舒伐他汀钙片对脑梗死患者血脂的影响。

方法

将125 例符合纳入标准 的脑梗死合并血脂异常的患者随机分为3 组, 其中A 组42 例, 采用温针灸结合口服瑞舒伐他汀钙片治疗; B 组40 例, 采用温针灸治疗; C 组43 例, 口服瑞舒伐他汀钙片治疗。

结果

治疗后, 3 组患者总胆固醇、甘油三酯、低密 度脂蛋白均较本组治疗前明显下降(均P<0.05), 改良Barthel 指数(BI)评分均有明显增加(均P<0.05), 高密度脂蛋 白升高均不明显(均P>0.05); 治疗后, 在总胆固醇(TC)、甘油三酯、低密度脂蛋白变化方面, A 组较B、C 两组明 显降低(均P<0.05), 但B、C 两组疗效相当(P>0.05), 3 组高密度脂蛋白结果无明显差异(均P>0.05); A、B 两组改 良BI 评分较C 组明显增加(均P<0.05), 但A、B 两组比较, 无明显差异(P>0.05)。治疗后, A 组总体疗效优于B 组 和C 组(均P<0.01), B 组与C 组无统计学差异(P>0.05)。

结论

温针灸及口服瑞舒伐他汀钙片均可有效的调节脑梗死患者的血脂水平, 且两者效果相当, 但两种方法联用降脂效果更加明显; 针灸在脑梗死患者神经功能恢复过程中发挥着重要作用。

关键词

针刺疗法 灸法 温针疗法 脑梗死 血脂 瑞舒伐他汀钙片 

中图分类号

R245.8 

文献标志码

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Notes

Acknowledgments

This work was supported by Key Discipline Funded Project of Chongqing City (重庆市重点学科基金资助项 目, No. 2008-47).

References

  1. [1]
    Chinese Neuroscience Society, Chinese Neurosurgical Society. Key diagnostic points for cerebrovascular diseases. Zhonghua Shenjingke Zazhi, 1996, 29(6): 379–380.Google Scholar
  2. [2]
    Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults. Chinese guidelines on prevention and treatment of dyslipidemia in adults. Zhonghua Xinxueguan Bing Zazhi, 2007, 35(5): 390–409.Google Scholar
  3. [3]
    Ministry of Health of the People’s Republic of China. Guiding Principles for Clinical Study of New Chinese Medicines. Beijing: China Medical Science Press, 2002: 89.Google Scholar
  4. [4]
    Jin H, Zhang HX. Clinical study on embedding thread at Fenglong point in the treatment of hyperlipemia. Zhenjiu Linchuang Zazhi, 2012, 28(4): 8–9.Google Scholar
  5. [5]
    Ma MY, Jiang JF, Zhou XY, Ji MY, Wang LL. Effect of moxibustion on blood fat and glucose in hyperlipemia patients. Shanghai Zhenjiu Zazhi, 2012, 31(8): 535–536.Google Scholar
  6. [6]
    Le W, Zhang HX, Wang Q, Huang GF, Zhou L, Qin PF. Modulatory effect of electroacupuncture at Fenglong (ST 40) on blood lipid and inflammatory factors in livers of rat hyperlipidemia model. Zhongguo Kangfu, 2015, 30(1): 7–9.Google Scholar
  7. [7]
    Guo AS, Li AH, Chen X, Zhu ZJ, Sun L. Clinical observation on needle-embedding method on Fenglong (ST 40) and Zusanli (ST 36) for lipid metabolism and homocysteine level on acute cerebral infarction patients. Zhongguo Laonianxue Zazhi, 2015, 35(12): 3310–3312.Google Scholar
  8. [8]
    He JF, Yan J, Huang HY, Li JS, Wang C, Li LD, Qu YT. Effect of puncturing acupoint from the Stomach Meridian on blood lipids and hypothalamic insulin receptor substrate-1 and serine phosphorylation activity in diet induced obese rats. Zhongyi Yanjiu, 2013, 26(2): 63–65.Google Scholar
  9. [9]
    Jones PH, Davidson MH, Stein EA, Bays HE, McKenney JM, Miller E, Cain VA, Blasetto JW; STELLAR Study Group. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial). Am J Cardiol, 2003, 92(2): 152–160.CrossRefPubMedGoogle Scholar
  10. [10]
    Nicholls SJ, Uno K, Kataoka Y. Clinical experience with rosuvastatin in the management of hyperlipidemia and the reduction of cardiovascular risk. Expert Rev Cardiovasc Ther, 2011, 9(11): 1383–1390.CrossRefPubMedGoogle Scholar
  11. [11]
    Ohsfeldt RL, Olsson AG, Jensen MM, Gandhi SK, Paulsson T. Cost-effectiveness of rosuvastatin 20 mg for the prevention of cardiovascular morbidity and mortality: a Swedish economic evaluation of the JUPITER trial. J Med Econ, 2012, 15(1): 125–133.CrossRefPubMedGoogle Scholar
  12. [12]
    He Y, Pan QD, Huang YK. Effects of rosuvastatin combined with Tongxinluo on carotid atherosclerotic plaque. Xiandai Zhongxiyi Jiehe Zazhi, 2013, 22(16): 1738–1739.Google Scholar
  13. [13]
    Carswell CI, Plosker GL, Jarvis B. Rosuvastatin. Drugs, 2002, 62(14): 2075–2085.CrossRefPubMedGoogle Scholar
  14. [14]
    Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM; ASTEROID Investigators. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA, 2006, 295(13): 1556–1565.CrossRefPubMedGoogle Scholar
  15. [15]
    Expert Group for Standard Action of China’ Clinical Blood Lipid Controlling. Expert recommendations on attaining the goal for treatment of hypercholesterolemia in clinical practice. Zhonghua Xinxueguanbing Zazhi, 2010, 38(4): 294–298.Google Scholar
  16. [16]
    Cao PL, Li NE, Sun YJ, Tang QZ, Liu JF. Dose-dependent efficacy and safety of rosuvastatin in dyslipidemia patients at high risk for cardiovascular diseases. Zhongguo Laonian Baojian Yixue, 2011, 9(3): 33–35.Google Scholar
  17. [17]
    Wang Y, Zhong MR, Wang Q, Wei LH. Effect of thunder-fire moxibustion on blood lipid and hemorheology in patients with coronary heart disease undergone interventional treatment. Shanghai Zhenjiu Zazhi, 2015, 34(11): 1056–1058.Google Scholar
  18. [18]
    Ma MY, Jiang JF, Zhou XY, Ji MY, Wang LL. Influence of suspended moxibustion on the biochemical markers of patients with hyperlipidemia. J Acupunct Tuina Sci, 2012, 10(9): 364–367.CrossRefGoogle Scholar

Copyright information

© Shanghai Research Institute of Acupuncture and Meridian and Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  • Zhen-jie Xu (徐贞杰)
    • 1
  • Wei Qi (漆伟)
    • 1
  • Yi Liu (刘奕)
    • 1
  1. 1.Rehabilitation DepartmentChongqing Three Gorges Central HospitalChongqingChina

Personalised recommendations